Three-dimensional, Scaffold-Free, Autologous Chondrocyte Transplantation: A Systematic Review
Overview
Affiliations
Background: A 3-dimensional, scaffold-free, and completely autologous form of chondrocyte transplantation (ACT3D) has been developed and applied in clinical practice in the past decade to overcome disadvantages of previous-generation procedures.
Purpose: To document and analyze the available literature on the results of ACT3D in the treatment of articular chondral lesions in the knee and hip joints.
Study Design: Systematic review; Level of evidence, 4.
Methods: All studies published in English addressing ACT3D were identified and included those that fulfilled the following criteria: (1) level 1 through 4 evidence, (2) measures of radiological or functional/clinical outcome, and (3) outcome related to cartilage lesions of the knee and hip joints.
Results: A total of 10 studies were selected: 2 randomized controlled trials, 1 cohort study, and 7 case series. The studies revealed significant increases in patients' subjective quality of life, satisfaction, pain reduction, and improvement in joint function at short- to medium-term follow-up. Magnetic resonance imaging-assisted examination and second-look arthroscopy showed a hyaline-like repair tissue with a high degree of defect filling and integration.
Conclusion: ACT3D shows promising results in the therapy of articular cartilage defects in the knee as well as in the hip, but well-designed, long-term studies are lacking. ACT3D might have relevant advantages over common matrix-associated autologous chondrocyte transplantation products, but systematic evaluation and randomized controlled studies are crucial to verify the potential of this tissue-engineered approach.
Charting a quarter-century of commercial cartilage regeneration products.
Liu X, Guo X, Pei Y, Pei M, Ge Z J Orthop Translat. 2025; 50:354-363.
PMID: 39968336 PMC: 11833628. DOI: 10.1016/j.jot.2024.10.009.
Park S, Son Y, Park J, Lee S, Kim N, Jang S Gels. 2025; 11(1).
PMID: 39852013 PMC: 11765300. DOI: 10.3390/gels11010042.
Management of chondral and osteochondral lesions of the hip : A comprehensive review.
Itha R, Vaishya R, Vaish A, Migliorini F Orthopadie (Heidelb). 2023; 53(1):23-38.
PMID: 37815635 PMC: 10781822. DOI: 10.1007/s00132-023-04444-9.
Cartilage Defect Treatment Using High-Density Autologous Chondrocyte Implantation (HD-ACI).
Guillen-Garcia P, Guillen-Vicente I, Rodriguez-Inigo E, Guillen-Vicente M, Fernandez-Jaen T, Navarro R Bioengineering (Basel). 2023; 10(9).
PMID: 37760185 PMC: 10525711. DOI: 10.3390/bioengineering10091083.
Nanomedicine and regenerative medicine approaches in osteoarthritis therapy.
Goudarzi R, Dehpour A, Partoazar A Aging Clin Exp Res. 2022; 34(10):2305-2315.
PMID: 35867240 DOI: 10.1007/s40520-022-02199-5.